BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9844620)

  • 1. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.
    Mendenhall WM; Parsons JT
    Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Amdur RJ; Siemann DW; Parsons JT
    Curr Opin Oncol; 2000 May; 12(3):207-14. PubMed ID: 10841192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fractionation radiotherapy in head and neck squamous cell carcinoma.
    Mallick S; Benson R; Julka PK; Rath GK
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):73-80. PubMed ID: 26994645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered fractionation in the treatment of head and neck cancer.
    Hu KS; Harrison LB
    Curr Oncol Rep; 1999; 1(2):110-23. PubMed ID: 11122807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfractionated or accelerated radiotherapy for head and neck cancer.
    Baujat B; Bourhis J; Blanchard P; Overgaard J; Ang KK; Saunders M; Le Maître A; Bernier J; Horiot JC; Maillard E; Pajak TF; Poulsen MG; Bourredjem A; O'Sullivan B; Dobrowsky W; Andrzej H; Skladowski K; Hay JH; Pinto LH; Fu KK; Fallai C; Sylvester R; Pignon JP;
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD002026. PubMed ID: 21154350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
    Lacas B; Bourhis J; Overgaard J; Zhang Q; Grégoire V; Nankivell M; Zackrisson B; Szutkowski Z; Suwiński R; Poulsen M; O'Sullivan B; Corvò R; Laskar SG; Fallai C; Yamazaki H; Dobrowsky W; Cho KH; Beadle B; Langendijk JA; Viegas CMP; Hay J; Lotayef M; Parmar MKB; Aupérin A; van Herpen C; Maingon P; Trotti AM; Grau C; Pignon JP; Blanchard P;
    Lancet Oncol; 2017 Sep; 18(9):1221-1237. PubMed ID: 28757375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
    Matuschek C; Haussmann J; Bölke E; Gripp S; Schuler PJ; Tamaskovics B; Gerber PA; Djiepmo-Njanang FJ; Kammers K; Plettenberg C; Anooshahr B; Orth K; Budach W
    Radiat Oncol; 2018 Oct; 13(1):195. PubMed ID: 30286777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell Carcinoma.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Shimizu D; Kimoto T; Nishimura T; Kawabata K; Nagasawa S; Machida K; Yoshino Y; Watanabe S; Sugiyama Y; Arai A; Hirano S; Yamada K
    In Vivo; 2020; 34(5):2769-2774. PubMed ID: 32871813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 14. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic overview of radiation therapy effects in head and neck cancer.
    Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fractionation for head and neck cancer.
    Garden AS
    Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered fractionation in the management of head and neck cancer.
    Ang KK
    Int J Radiat Biol; 1998 Apr; 73(4):395-9. PubMed ID: 9587077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B; Shibamoto Y; Igrutinovic I
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):687-91. PubMed ID: 11710599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.